Entera Bio (ENTX) Director Taitel Haya Receives 20,790-Share Award

What Happened
Taitel Haya, a director of Entera Bio Ltd. (ENTX), was awarded 20,790 shares on August 7, 2026. The shares were granted in lieu of cash fees owed for the first and second quarters of 2026; the reported acquisition price is $0.00 because the award replaced cash compensation. The grant was approved by the Board on August 5, 2026 and became effective upon the Company’s filing of a Form S-8 registration statement on August 7, 2026.

Key Details

• Transaction date: 2026-08-07; Transaction code: A (award/grant)
• Shares acquired: 20,790; reported price per share: $0.00; total reported value: $0
• Board approval date: August 5, 2026; Form S-8 registration filed: August 7, 2026 (required for issuance)
• Shares owned after transaction: Not specified in the provided filing
• Filing timeliness: Reported for the same date as the transaction (no late filing indicated)
• Footnote: Grant was explicitly made in lieu of cash director fees for Q1 and Q2 2026 (see F1)

Context
Awards in lieu of cash are a common way to compensate directors and do not necessarily indicate the director’s market sentiment. Because these shares were issued instead of cash and required registration on Form S-8, the company completed the registration before the shares were reported as acquired. This transaction is an equity award to a director, not a market purchase or sale.